ImmuCell Corporation logo

ImmuCell Corporation

ICCC | NASDAQ
Chart Builder DCF Calculator
$10.44
+$0.18 (+1.75%)
Nov 2, 2026, 10:47 AM ET · Market open
Fiscal Year
Period Ending
FY 2025
Dec 31, 2025
FY 2024
Dec 31, 2024
FY 2023
Dec 31, 2023
FY 2022
Dec 31, 2022
FY 2021
Dec 31, 2021
FY 2020
Dec 31, 2020
Cash & Equivalents
3.81M 3.76M 978.74K 5.79M 10.19M 7.95M
Short-Term Investments
n/a n/a n/a n/a -468 n/a
Long-Term Investments
n/a n/a n/a n/a n/a n/a
Other Long-Term Assets
25.49M 33.37K 57.66K 76.63K 26.12K 26.17K
Receivables
3.42M 3.81M 2.19M 1.8M 2.72M 1.86M
Inventory
9.27M 7.11M 7.81M 6.04M 3.09M 2.09M
Other Current Assets
31.38K n/a 39.73K n/a n/a 800
Total Current Assets
16.94M 15.04M 11.47M 13.99M 16.26M 12.16M
Property-Plant & Equipment
n/a 29.91M 32.15M 30.64M 28M 27.98M
Goodwill & Intangibles
95.56K 114.66K 133.77K 152.87K 171.97K 191.08K
Total Long-Term Assets
25.59M 30.06M 32.34M 30.87M 28.2M 28.19M
Total Assets
42.53M 45.1M 43.81M 44.86M 44.47M 40.35M
Account Payables
796.29K 943.64K 887.73K 790K 745.04K 602.35K
Deferred Revenue
n/a n/a n/a n/a n/a n/a
Short-Term Debt
1.61M 1.5M 1.43M 1.04M 812.21K 760.34K
Other Current Liabilities
n/a n/a 306.78K n/a n/a n/a
Total Current Liabilities
3.98M 4.41M 4.2M 3.07M 2.53M 2.21M
Long-Term Debt
7.49M 9.04M 10.54M 9.19M 8.33M 8.74M
Other Long-Term Liabilities
n/a n/a n/a n/a n/a n/a
Total Long-Term Liabilities
11.5M 13.17M 14.62M 11.41M 9.35M 9.87M
Total Liabilities
15.48M 17.58M 18.82M 14.48M 11.89M 12.08M
Total Debt
13.19M 15.1M 16.69M 12.48M 10.27M 10.73M
Book Value
27.06M 27.52M 24.99M 30.38M 32.58M 28.27M
Book Value Per Share
3 3.37 3.23 3.92 4.29 3.92
Common Stock
910.56K 904.24K 781.42K 781.42K 781.42K 729.9K
Retained Earnings
-15.2M -14.16M -12.01M -6.23M -3.74M -3.66M
Comprehensive Income
n/a n/a 0 0 0 n/a
Shareholders Equity
27.06M 27.52M 24.99M 30.38M 32.58M 28.27M
Total Investments
n/a n/a n/a n/a -468 n/a

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.